ESSA Pharma Inc
NASDAQ:EPIX
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
ROE Comparison
ESSA Pharma Inc Competitors
| Country | CA |
| Market Cap | 276m USD |
| ROE |
-17%
|
| Country | US |
| Market Cap | 295.7B USD |
| ROE |
35%
|
| Country | US |
| Market Cap | 143.7B USD |
| ROE |
136%
|
| Country | US |
| Market Cap | 102.5B USD |
| ROE |
23%
|
| Country | US |
| Market Cap | 97.6B USD |
| ROE |
16%
|
| Country | AU |
| Market Cap | 134.5B AUD |
| ROE |
15%
|
| Country | US |
| Market Cap | 81.5B USD |
| ROE |
26%
|
| Country | US |
| Market Cap | 43.1B USD |
| ROE |
-28%
|
| Country | US |
| Market Cap | 40.1B USD |
| ROE |
-29%
|
| Country | US |
| Market Cap | 28.9B USD |
| ROE |
8%
|
| Country | KR |
| Market Cap | 36.8T KRW |
| ROE |
5%
|
Profitability Report
View the profitability report to see the full profitability analysis for ESSA Pharma Inc.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on ESSA Pharma Inc's most recent financial statements, the company has ROE of -17.1%.
You don't have any saved screeners yet
